More than 500 people will be recruited for a £2m clinical trial hosted in Wolverhampton which will be a world-leading study in treatment of a common cause of diarrhoea.
Three potential treatments for the symptoms of bile acid diarrhoea (BAD) will be examined in the four-year study, funded by the National Institute for Health and Care Research, with hopes the first recruit will be on board this month.
